Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

/sup 3/H-cimetidine and the H/sub 2/-receptor

Journal Article · · Life Sci.; (United States)

The H/sub 2/-antagonist cimetidine is widely employed in biochemical and pharmacological studies of the H/sub 2/-receptor. These studies include the use of /sup 3/H-cimetidine in radioligand binding experiments. Confirming our previous finding as to the unsuitability of this ligand in these types of investigations, we now report data showing the lack of correlation between the displacement of specific /sup 3/H-cimetidine binding and histamine stimulated adenylate cyclase activity, and the displacement of specific binding by imidazoles devoid of H/sub 2/-receptor activity. Results are also presented which question the use of copper ions in /sup 3/H-cimetidine binding studies. Our conclusions are discussed in relation to the work carried out by a number of laboratories where /sup 3/H-cimetidine is reported to label the H/sub 2/-receptor. 30 references, 2 figures, 2 tables.

Research Organization:
Hoechst Pharmaceutical Research Laboratories, Milton Keynes, England
OSTI ID:
6101232
Journal Information:
Life Sci.; (United States), Journal Name: Life Sci.; (United States) Vol. 33:12; ISSN LIFSA
Country of Publication:
United States
Language:
English